Global Multi-cancer Early Detection (MCED) Tests Market Research Report 2026(Status and Outlook)
The Multiple Cancer Early Detection (MCED) test is a blood test designed to detect multiple cancer types early, potentially before symptoms appear. Often referred to as liquid biopsies, these tests identify cancer signatures by analyzing circulating tumor DNA (ctDNA) and other biomarkers in the blood. While still under evaluation, the MCED test has the potential to revolutionize cancer screening because it has the potential to detect cancers not covered by current screening methods and increase overall early detection rates.
The global Multi-cancer Early Detection (MCED) Tests market size was estimated at USD 875.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Multi-cancer Early Detection (MCED) Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Multi-cancer Early Detection (MCED) Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Multi-cancer Early Detection (MCED) Tests market.
Global Multi-cancer Early Detection (MCED) Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Guardant Health
Exact Sciences
Freenome
Epiginomics AG
Bio-techne
ThriveEarlier Detection
GRAIL, Inc.
CellMax life
Berry Genomics
Singlera Genomics
Geneseeq
BGI Genomics
Burning Rock Biotech Limited
New Horizon Health Limited
Yeasen Bio
Hangzhou Aoru Biotech
Amoy Diagnostics Co., Ltd.
Genetron Health
AnchorDx
Surexam Bio-Tech Co.,Ltd.
HaploX
HefeiLaierBiotechnologyCo.,Ltd
Market Segmentation (by Type)
ctDNA Detection
CTC Detection
Exosome Detection
Market Segmentation (by Application)
Medical Institutions
Physical Examination Centers
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Multi-cancer Early Detection (MCED) Tests Market
Overview of the regional outlook of the Multi-cancer Early Detection (MCED) Tests Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Multi-cancer Early Detection (MCED) Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Multi-cancer Early Detection (MCED) Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Multi-cancer Early Detection (MCED) Tests market size was estimated at USD 875.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Multi-cancer Early Detection (MCED) Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Multi-cancer Early Detection (MCED) Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Multi-cancer Early Detection (MCED) Tests market.
Global Multi-cancer Early Detection (MCED) Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Guardant Health
Exact Sciences
Freenome
Epiginomics AG
Bio-techne
ThriveEarlier Detection
GRAIL, Inc.
CellMax life
Berry Genomics
Singlera Genomics
Geneseeq
BGI Genomics
Burning Rock Biotech Limited
New Horizon Health Limited
Yeasen Bio
Hangzhou Aoru Biotech
Amoy Diagnostics Co., Ltd.
Genetron Health
AnchorDx
Surexam Bio-Tech Co.,Ltd.
HaploX
HefeiLaierBiotechnologyCo.,Ltd
Market Segmentation (by Type)
ctDNA Detection
CTC Detection
Exosome Detection
Market Segmentation (by Application)
Medical Institutions
Physical Examination Centers
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Multi-cancer Early Detection (MCED) Tests Market
Overview of the regional outlook of the Multi-cancer Early Detection (MCED) Tests Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Multi-cancer Early Detection (MCED) Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Multi-cancer Early Detection (MCED) Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Multi-cancer Early Detection (MCED) Tests
1.2 Key Market Segments
1.2.1 Multi-cancer Early Detection (MCED) Tests Segment by Type
1.2.2 Multi-cancer Early Detection (MCED) Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Multi-cancer Early Detection (MCED) Tests Product Life Cycle
3.3 Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Company (2020-2025)
3.4 Multi-cancer Early Detection (MCED) Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Multi-cancer Early Detection (MCED) Tests Market Competitive Situation and Trends
3.6.1 Multi-cancer Early Detection (MCED) Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Multi-cancer Early Detection (MCED) Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MULTI-CANCER EARLY DETECTION (MCED) TESTS VALUE CHAIN ANALYSIS
4.1 Multi-cancer Early Detection (MCED) Tests Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Multi-cancer Early Detection (MCED) Tests Market Porter's Five Forces Analysis
6 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Multi-cancer Early Detection (MCED) Tests Market by Type (2020-2025)
6.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (2021-2025)
7 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) by Application (2020-2025)
7.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (2021-2025)
8 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET SEGMENTATION BY REGION
8.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.1.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.1.2 Global Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region
8.2 North America
8.2.1 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Multi-cancer Early Detection (MCED) Tests Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Guardant Health
9.1.1 Guardant Health Basic Information
9.1.2 Guardant Health Multi-cancer Early Detection (MCED) Tests Product Overview
9.1.3 Guardant Health Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.1.4 Guardant Health SWOT Analysis
9.1.5 Guardant Health Business Overview
9.1.6 Guardant Health Recent Developments
9.2 Exact Sciences
9.2.1 Exact Sciences Basic Information
9.2.2 Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Overview
9.2.3 Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.2.4 Exact Sciences SWOT Analysis
9.2.5 Exact Sciences Business Overview
9.2.6 Exact Sciences Recent Developments
9.3 Freenome
9.3.1 Freenome Basic Information
9.3.2 Freenome Multi-cancer Early Detection (MCED) Tests Product Overview
9.3.3 Freenome Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.3.4 Freenome SWOT Analysis
9.3.5 Freenome Business Overview
9.3.6 Freenome Recent Developments
9.4 Epiginomics AG
9.4.1 Epiginomics AG Basic Information
9.4.2 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Overview
9.4.3 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.4.4 Epiginomics AG Business Overview
9.4.5 Epiginomics AG Recent Developments
9.5 Bio-techne
9.5.1 Bio-techne Basic Information
9.5.2 Bio-techne Multi-cancer Early Detection (MCED) Tests Product Overview
9.5.3 Bio-techne Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.5.4 Bio-techne Business Overview
9.5.5 Bio-techne Recent Developments
9.6 ThriveEarlier Detection
9.6.1 ThriveEarlier Detection Basic Information
9.6.2 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Overview
9.6.3 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.6.4 ThriveEarlier Detection Business Overview
9.6.5 ThriveEarlier Detection Recent Developments
9.7 GRAIL, Inc.
9.7.1 GRAIL, Inc. Basic Information
9.7.2 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Overview
9.7.3 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.7.4 GRAIL, Inc. Business Overview
9.7.5 GRAIL, Inc. Recent Developments
9.8 CellMax life
9.8.1 CellMax life Basic Information
9.8.2 CellMax life Multi-cancer Early Detection (MCED) Tests Product Overview
9.8.3 CellMax life Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.8.4 CellMax life Business Overview
9.8.5 CellMax life Recent Developments
9.9 Berry Genomics
9.9.1 Berry Genomics Basic Information
9.9.2 Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
9.9.3 Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.9.4 Berry Genomics Business Overview
9.9.5 Berry Genomics Recent Developments
9.10 Singlera Genomics
9.10.1 Singlera Genomics Basic Information
9.10.2 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
9.10.3 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.10.4 Singlera Genomics Business Overview
9.10.5 Singlera Genomics Recent Developments
9.11 Geneseeq
9.11.1 Geneseeq Basic Information
9.11.2 Geneseeq Multi-cancer Early Detection (MCED) Tests Product Overview
9.11.3 Geneseeq Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.11.4 Geneseeq Business Overview
9.11.5 Geneseeq Recent Developments
9.12 BGI Genomics
9.12.1 BGI Genomics Basic Information
9.12.2 BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
9.12.3 BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.12.4 BGI Genomics Business Overview
9.12.5 BGI Genomics Recent Developments
9.13 Burning Rock Biotech Limited
9.13.1 Burning Rock Biotech Limited Basic Information
9.13.2 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Overview
9.13.3 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.13.4 Burning Rock Biotech Limited Business Overview
9.13.5 Burning Rock Biotech Limited Recent Developments
9.14 New Horizon Health Limited
9.14.1 New Horizon Health Limited Basic Information
9.14.2 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Overview
9.14.3 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.14.4 New Horizon Health Limited Business Overview
9.14.5 New Horizon Health Limited Recent Developments
9.15 Yeasen Bio
9.15.1 Yeasen Bio Basic Information
9.15.2 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Overview
9.15.3 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.15.4 Yeasen Bio Business Overview
9.15.5 Yeasen Bio Recent Developments
9.16 Hangzhou Aoru Biotech
9.16.1 Hangzhou Aoru Biotech Basic Information
9.16.2 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Overview
9.16.3 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.16.4 Hangzhou Aoru Biotech Business Overview
9.16.5 Hangzhou Aoru Biotech Recent Developments
9.17 Amoy Diagnostics Co., Ltd.
9.17.1 Amoy Diagnostics Co., Ltd. Basic Information
9.17.2 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
9.17.3 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.17.4 Amoy Diagnostics Co., Ltd. Business Overview
9.17.5 Amoy Diagnostics Co., Ltd. Recent Developments
9.18 Genetron Health
9.18.1 Genetron Health Basic Information
9.18.2 Genetron Health Multi-cancer Early Detection (MCED) Tests Product Overview
9.18.3 Genetron Health Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.18.4 Genetron Health Business Overview
9.18.5 Genetron Health Recent Developments
9.19 AnchorDx
9.19.1 AnchorDx Basic Information
9.19.2 AnchorDx Multi-cancer Early Detection (MCED) Tests Product Overview
9.19.3 AnchorDx Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.19.4 AnchorDx Business Overview
9.19.5 AnchorDx Recent Developments
9.20 Surexam Bio-Tech Co.,Ltd.
9.20.1 Surexam Bio-Tech Co.,Ltd. Basic Information
9.20.2 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
9.20.3 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.20.4 Surexam Bio-Tech Co.,Ltd. Business Overview
9.20.5 Surexam Bio-Tech Co.,Ltd. Recent Developments
9.21 HaploX
9.21.1 HaploX Basic Information
9.21.2 HaploX Multi-cancer Early Detection (MCED) Tests Product Overview
9.21.3 HaploX Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.21.4 HaploX Business Overview
9.21.5 HaploX Recent Developments
9.22 HefeiLaierBiotechnologyCo.,Ltd
9.22.1 HefeiLaierBiotechnologyCo.,Ltd Basic Information
9.22.2 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Overview
9.22.3 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.22.4 HefeiLaierBiotechnologyCo.,Ltd Business Overview
9.22.5 HefeiLaierBiotechnologyCo.,Ltd Recent Developments
10 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET FORECAST BY REGION
10.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast
10.2 Global Multi-cancer Early Detection (MCED) Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country
10.2.3 Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Region
10.2.4 South America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Multi-cancer Early Detection (MCED) Tests by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Multi-cancer Early Detection (MCED) Tests Market Forecast by Type (2026-2035)
11.1.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Type (2026-2035)
11.2 Global Multi-cancer Early Detection (MCED) Tests Market Forecast by Application (2026-2035)
11.2.1 Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Multi-cancer Early Detection (MCED) Tests
1.2 Key Market Segments
1.2.1 Multi-cancer Early Detection (MCED) Tests Segment by Type
1.2.2 Multi-cancer Early Detection (MCED) Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Multi-cancer Early Detection (MCED) Tests Product Life Cycle
3.3 Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Company (2020-2025)
3.4 Multi-cancer Early Detection (MCED) Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Multi-cancer Early Detection (MCED) Tests Market Competitive Situation and Trends
3.6.1 Multi-cancer Early Detection (MCED) Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Multi-cancer Early Detection (MCED) Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MULTI-CANCER EARLY DETECTION (MCED) TESTS VALUE CHAIN ANALYSIS
4.1 Multi-cancer Early Detection (MCED) Tests Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Multi-cancer Early Detection (MCED) Tests Market Porter's Five Forces Analysis
6 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Multi-cancer Early Detection (MCED) Tests Market by Type (2020-2025)
6.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (2021-2025)
7 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) by Application (2020-2025)
7.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (2021-2025)
8 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET SEGMENTATION BY REGION
8.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.1.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.1.2 Global Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region
8.2 North America
8.2.1 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Multi-cancer Early Detection (MCED) Tests Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Guardant Health
9.1.1 Guardant Health Basic Information
9.1.2 Guardant Health Multi-cancer Early Detection (MCED) Tests Product Overview
9.1.3 Guardant Health Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.1.4 Guardant Health SWOT Analysis
9.1.5 Guardant Health Business Overview
9.1.6 Guardant Health Recent Developments
9.2 Exact Sciences
9.2.1 Exact Sciences Basic Information
9.2.2 Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Overview
9.2.3 Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.2.4 Exact Sciences SWOT Analysis
9.2.5 Exact Sciences Business Overview
9.2.6 Exact Sciences Recent Developments
9.3 Freenome
9.3.1 Freenome Basic Information
9.3.2 Freenome Multi-cancer Early Detection (MCED) Tests Product Overview
9.3.3 Freenome Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.3.4 Freenome SWOT Analysis
9.3.5 Freenome Business Overview
9.3.6 Freenome Recent Developments
9.4 Epiginomics AG
9.4.1 Epiginomics AG Basic Information
9.4.2 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Overview
9.4.3 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.4.4 Epiginomics AG Business Overview
9.4.5 Epiginomics AG Recent Developments
9.5 Bio-techne
9.5.1 Bio-techne Basic Information
9.5.2 Bio-techne Multi-cancer Early Detection (MCED) Tests Product Overview
9.5.3 Bio-techne Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.5.4 Bio-techne Business Overview
9.5.5 Bio-techne Recent Developments
9.6 ThriveEarlier Detection
9.6.1 ThriveEarlier Detection Basic Information
9.6.2 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Overview
9.6.3 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.6.4 ThriveEarlier Detection Business Overview
9.6.5 ThriveEarlier Detection Recent Developments
9.7 GRAIL, Inc.
9.7.1 GRAIL, Inc. Basic Information
9.7.2 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Overview
9.7.3 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.7.4 GRAIL, Inc. Business Overview
9.7.5 GRAIL, Inc. Recent Developments
9.8 CellMax life
9.8.1 CellMax life Basic Information
9.8.2 CellMax life Multi-cancer Early Detection (MCED) Tests Product Overview
9.8.3 CellMax life Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.8.4 CellMax life Business Overview
9.8.5 CellMax life Recent Developments
9.9 Berry Genomics
9.9.1 Berry Genomics Basic Information
9.9.2 Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
9.9.3 Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.9.4 Berry Genomics Business Overview
9.9.5 Berry Genomics Recent Developments
9.10 Singlera Genomics
9.10.1 Singlera Genomics Basic Information
9.10.2 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
9.10.3 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.10.4 Singlera Genomics Business Overview
9.10.5 Singlera Genomics Recent Developments
9.11 Geneseeq
9.11.1 Geneseeq Basic Information
9.11.2 Geneseeq Multi-cancer Early Detection (MCED) Tests Product Overview
9.11.3 Geneseeq Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.11.4 Geneseeq Business Overview
9.11.5 Geneseeq Recent Developments
9.12 BGI Genomics
9.12.1 BGI Genomics Basic Information
9.12.2 BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
9.12.3 BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.12.4 BGI Genomics Business Overview
9.12.5 BGI Genomics Recent Developments
9.13 Burning Rock Biotech Limited
9.13.1 Burning Rock Biotech Limited Basic Information
9.13.2 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Overview
9.13.3 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.13.4 Burning Rock Biotech Limited Business Overview
9.13.5 Burning Rock Biotech Limited Recent Developments
9.14 New Horizon Health Limited
9.14.1 New Horizon Health Limited Basic Information
9.14.2 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Overview
9.14.3 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.14.4 New Horizon Health Limited Business Overview
9.14.5 New Horizon Health Limited Recent Developments
9.15 Yeasen Bio
9.15.1 Yeasen Bio Basic Information
9.15.2 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Overview
9.15.3 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.15.4 Yeasen Bio Business Overview
9.15.5 Yeasen Bio Recent Developments
9.16 Hangzhou Aoru Biotech
9.16.1 Hangzhou Aoru Biotech Basic Information
9.16.2 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Overview
9.16.3 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.16.4 Hangzhou Aoru Biotech Business Overview
9.16.5 Hangzhou Aoru Biotech Recent Developments
9.17 Amoy Diagnostics Co., Ltd.
9.17.1 Amoy Diagnostics Co., Ltd. Basic Information
9.17.2 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
9.17.3 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.17.4 Amoy Diagnostics Co., Ltd. Business Overview
9.17.5 Amoy Diagnostics Co., Ltd. Recent Developments
9.18 Genetron Health
9.18.1 Genetron Health Basic Information
9.18.2 Genetron Health Multi-cancer Early Detection (MCED) Tests Product Overview
9.18.3 Genetron Health Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.18.4 Genetron Health Business Overview
9.18.5 Genetron Health Recent Developments
9.19 AnchorDx
9.19.1 AnchorDx Basic Information
9.19.2 AnchorDx Multi-cancer Early Detection (MCED) Tests Product Overview
9.19.3 AnchorDx Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.19.4 AnchorDx Business Overview
9.19.5 AnchorDx Recent Developments
9.20 Surexam Bio-Tech Co.,Ltd.
9.20.1 Surexam Bio-Tech Co.,Ltd. Basic Information
9.20.2 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
9.20.3 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.20.4 Surexam Bio-Tech Co.,Ltd. Business Overview
9.20.5 Surexam Bio-Tech Co.,Ltd. Recent Developments
9.21 HaploX
9.21.1 HaploX Basic Information
9.21.2 HaploX Multi-cancer Early Detection (MCED) Tests Product Overview
9.21.3 HaploX Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.21.4 HaploX Business Overview
9.21.5 HaploX Recent Developments
9.22 HefeiLaierBiotechnologyCo.,Ltd
9.22.1 HefeiLaierBiotechnologyCo.,Ltd Basic Information
9.22.2 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Overview
9.22.3 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Market Performance
9.22.4 HefeiLaierBiotechnologyCo.,Ltd Business Overview
9.22.5 HefeiLaierBiotechnologyCo.,Ltd Recent Developments
10 MULTI-CANCER EARLY DETECTION (MCED) TESTS MARKET FORECAST BY REGION
10.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast
10.2 Global Multi-cancer Early Detection (MCED) Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country
10.2.3 Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Region
10.2.4 South America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Multi-cancer Early Detection (MCED) Tests by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Multi-cancer Early Detection (MCED) Tests Market Forecast by Type (2026-2035)
11.1.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Type (2026-2035)
11.2 Global Multi-cancer Early Detection (MCED) Tests Market Forecast by Application (2026-2035)
11.2.1 Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (M USD)
Table 4. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application
Table 5. Multi-cancer Early Detection (MCED) Tests Market Size Comparison by Region (M USD)
Table 6. Global Multi-cancer Early Detection (MCED) Tests Revenue (M USD) by Company (2020-2025)
Table 7. Global Multi-cancer Early Detection (MCED) Tests Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-cancer Early Detection (MCED) Tests as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Multi-cancer Early Detection (MCED) Tests Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Multi-cancer Early Detection (MCED) Tests Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (M USD)
Table 22. Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) by Type (2020-2025)
Table 23. Global Multi-cancer Early Detection (MCED) Tests Market Share by Type (2020-2025)
Table 24. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (2021-2025)
Table 25. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application
Table 26. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2020-2025) & (M USD)
Table 27. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application (2020-2025)
Table 28. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (2021-2025)
Table 29. Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2020-2025) & (M USD)
Table 30. Global Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region (2020-2025)
Table 31. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Region (2020-2025) & (M USD)
Table 34. South America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size by Region (2020-2025) & (M USD)
Table 36. Guardant Health Basic Information
Table 37. Guardant Health Multi-cancer Early Detection (MCED) Tests Product Overview
Table 38. Guardant Health Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Guardant Health SWOT Analysis
Table 40. Guardant Health Business Overview
Table 41. Guardant Health Recent Developments
Table 42. Exact Sciences Basic Information
Table 43. Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Overview
Table 44. Exact Sciences Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Exact Sciences SWOT Analysis
Table 46. Exact Sciences Business Overview
Table 47. Exact Sciences Recent Developments
Table 48. Freenome Basic Information
Table 49. Freenome Multi-cancer Early Detection (MCED) Tests Product Overview
Table 50. Freenome Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Freenome SWOT Analysis
Table 52. Freenome Business Overview
Table 53. Freenome Recent Developments
Table 54. Epiginomics AG Basic Information
Table 55. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Overview
Table 56. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Epiginomics AG Business Overview
Table 58. Epiginomics AG Recent Developments
Table 59. Bio-techne Basic Information
Table 60. Bio-techne Multi-cancer Early Detection (MCED) Tests Product Overview
Table 61. Bio-techne Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Bio-techne Business Overview
Table 63. Bio-techne Recent Developments
Table 64. ThriveEarlier Detection Basic Information
Table 65. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Overview
Table 66. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 67. ThriveEarlier Detection Business Overview
Table 68. ThriveEarlier Detection Recent Developments
Table 69. GRAIL, Inc. Basic Information
Table 70. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Overview
Table 71. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 72. GRAIL, Inc. Business Overview
Table 73. GRAIL, Inc. Recent Developments
Table 74. CellMax life Basic Information
Table 75. CellMax life Multi-cancer Early Detection (MCED) Tests Product Overview
Table 76. CellMax life Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 77. CellMax life Business Overview
Table 78. CellMax life Recent Developments
Table 79. Berry Genomics Basic Information
Table 80. Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
Table 81. Berry Genomics Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Berry Genomics Business Overview
Table 83. Berry Genomics Recent Developments
Table 84. Singlera Genomics Basic Information
Table 85. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
Table 86. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Singlera Genomics Business Overview
Table 88. Singlera Genomics Recent Developments
Table 89. Geneseeq Basic Information
Table 90. Geneseeq Multi-cancer Early Detection (MCED) Tests Product Overview
Table 91. Geneseeq Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Geneseeq Business Overview
Table 93. Geneseeq Recent Developments
Table 94. BGI Genomics Basic Information
Table 95. BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
Table 96. BGI Genomics Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 97. BGI Genomics Business Overview
Table 98. BGI Genomics Recent Developments
Table 99. Burning Rock Biotech Limited Basic Information
Table 100. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Overview
Table 101. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Burning Rock Biotech Limited Business Overview
Table 103. Burning Rock Biotech Limited Recent Developments
Table 104. New Horizon Health Limited Basic Information
Table 105. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Overview
Table 106. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 107. New Horizon Health Limited Business Overview
Table 108. New Horizon Health Limited Recent Developments
Table 109. Yeasen Bio Basic Information
Table 110. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Overview
Table 111. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Yeasen Bio Business Overview
Table 113. Yeasen Bio Recent Developments
Table 114. Hangzhou Aoru Biotech Basic Information
Table 115. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Overview
Table 116. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Hangzhou Aoru Biotech Business Overview
Table 118. Hangzhou Aoru Biotech Recent Developments
Table 119. Amoy Diagnostics Co., Ltd. Basic Information
Table 120. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
Table 121. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Amoy Diagnostics Co., Ltd. Business Overview
Table 123. Amoy Diagnostics Co., Ltd. Recent Developments
Table 124. Genetron Health Basic Information
Table 125. Genetron Health Multi-cancer Early Detection (MCED) Tests Product Overview
Table 126. Genetron Health Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Genetron Health Business Overview
Table 128. Genetron Health Recent Developments
Table 129. AnchorDx Basic Information
Table 130. AnchorDx Multi-cancer Early Detection (MCED) Tests Product Overview
Table 131. AnchorDx Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 132. AnchorDx Business Overview
Table 133. AnchorDx Recent Developments
Table 134. Surexam Bio-Tech Co.,Ltd. Basic Information
Table 135. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
Table 136. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Surexam Bio-Tech Co.,Ltd. Business Overview
Table 138. Surexam Bio-Tech Co.,Ltd. Recent Developments
Table 139. HaploX Basic Information
Table 140. HaploX Multi-cancer Early Detection (MCED) Tests Product Overview
Table 141. HaploX Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 142. HaploX Business Overview
Table 143. HaploX Recent Developments
Table 144. HefeiLaierBiotechnologyCo.,Ltd Basic Information
Table 145. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Overview
Table 146. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 147. HefeiLaierBiotechnologyCo.,Ltd Business Overview
Table 148. HefeiLaierBiotechnologyCo.,Ltd Recent Developments
Table 149. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 150. North America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Europe Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Type (2026-2035) & (M USD)
Table 156. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (M USD)
Table 4. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application
Table 5. Multi-cancer Early Detection (MCED) Tests Market Size Comparison by Region (M USD)
Table 6. Global Multi-cancer Early Detection (MCED) Tests Revenue (M USD) by Company (2020-2025)
Table 7. Global Multi-cancer Early Detection (MCED) Tests Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-cancer Early Detection (MCED) Tests as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Multi-cancer Early Detection (MCED) Tests Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Multi-cancer Early Detection (MCED) Tests Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (M USD)
Table 22. Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) by Type (2020-2025)
Table 23. Global Multi-cancer Early Detection (MCED) Tests Market Share by Type (2020-2025)
Table 24. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (2021-2025)
Table 25. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application
Table 26. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2020-2025) & (M USD)
Table 27. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application (2020-2025)
Table 28. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (2021-2025)
Table 29. Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2020-2025) & (M USD)
Table 30. Global Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region (2020-2025)
Table 31. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Region (2020-2025) & (M USD)
Table 34. South America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size by Region (2020-2025) & (M USD)
Table 36. Guardant Health Basic Information
Table 37. Guardant Health Multi-cancer Early Detection (MCED) Tests Product Overview
Table 38. Guardant Health Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Guardant Health SWOT Analysis
Table 40. Guardant Health Business Overview
Table 41. Guardant Health Recent Developments
Table 42. Exact Sciences Basic Information
Table 43. Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Overview
Table 44. Exact Sciences Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Exact Sciences SWOT Analysis
Table 46. Exact Sciences Business Overview
Table 47. Exact Sciences Recent Developments
Table 48. Freenome Basic Information
Table 49. Freenome Multi-cancer Early Detection (MCED) Tests Product Overview
Table 50. Freenome Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Freenome SWOT Analysis
Table 52. Freenome Business Overview
Table 53. Freenome Recent Developments
Table 54. Epiginomics AG Basic Information
Table 55. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Overview
Table 56. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Epiginomics AG Business Overview
Table 58. Epiginomics AG Recent Developments
Table 59. Bio-techne Basic Information
Table 60. Bio-techne Multi-cancer Early Detection (MCED) Tests Product Overview
Table 61. Bio-techne Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Bio-techne Business Overview
Table 63. Bio-techne Recent Developments
Table 64. ThriveEarlier Detection Basic Information
Table 65. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Overview
Table 66. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 67. ThriveEarlier Detection Business Overview
Table 68. ThriveEarlier Detection Recent Developments
Table 69. GRAIL, Inc. Basic Information
Table 70. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Overview
Table 71. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 72. GRAIL, Inc. Business Overview
Table 73. GRAIL, Inc. Recent Developments
Table 74. CellMax life Basic Information
Table 75. CellMax life Multi-cancer Early Detection (MCED) Tests Product Overview
Table 76. CellMax life Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 77. CellMax life Business Overview
Table 78. CellMax life Recent Developments
Table 79. Berry Genomics Basic Information
Table 80. Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
Table 81. Berry Genomics Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Berry Genomics Business Overview
Table 83. Berry Genomics Recent Developments
Table 84. Singlera Genomics Basic Information
Table 85. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
Table 86. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Singlera Genomics Business Overview
Table 88. Singlera Genomics Recent Developments
Table 89. Geneseeq Basic Information
Table 90. Geneseeq Multi-cancer Early Detection (MCED) Tests Product Overview
Table 91. Geneseeq Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Geneseeq Business Overview
Table 93. Geneseeq Recent Developments
Table 94. BGI Genomics Basic Information
Table 95. BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Overview
Table 96. BGI Genomics Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 97. BGI Genomics Business Overview
Table 98. BGI Genomics Recent Developments
Table 99. Burning Rock Biotech Limited Basic Information
Table 100. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Overview
Table 101. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Burning Rock Biotech Limited Business Overview
Table 103. Burning Rock Biotech Limited Recent Developments
Table 104. New Horizon Health Limited Basic Information
Table 105. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Overview
Table 106. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 107. New Horizon Health Limited Business Overview
Table 108. New Horizon Health Limited Recent Developments
Table 109. Yeasen Bio Basic Information
Table 110. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Overview
Table 111. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Yeasen Bio Business Overview
Table 113. Yeasen Bio Recent Developments
Table 114. Hangzhou Aoru Biotech Basic Information
Table 115. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Overview
Table 116. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Hangzhou Aoru Biotech Business Overview
Table 118. Hangzhou Aoru Biotech Recent Developments
Table 119. Amoy Diagnostics Co., Ltd. Basic Information
Table 120. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
Table 121. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Amoy Diagnostics Co., Ltd. Business Overview
Table 123. Amoy Diagnostics Co., Ltd. Recent Developments
Table 124. Genetron Health Basic Information
Table 125. Genetron Health Multi-cancer Early Detection (MCED) Tests Product Overview
Table 126. Genetron Health Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Genetron Health Business Overview
Table 128. Genetron Health Recent Developments
Table 129. AnchorDx Basic Information
Table 130. AnchorDx Multi-cancer Early Detection (MCED) Tests Product Overview
Table 131. AnchorDx Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 132. AnchorDx Business Overview
Table 133. AnchorDx Recent Developments
Table 134. Surexam Bio-Tech Co.,Ltd. Basic Information
Table 135. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Overview
Table 136. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Surexam Bio-Tech Co.,Ltd. Business Overview
Table 138. Surexam Bio-Tech Co.,Ltd. Recent Developments
Table 139. HaploX Basic Information
Table 140. HaploX Multi-cancer Early Detection (MCED) Tests Product Overview
Table 141. HaploX Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 142. HaploX Business Overview
Table 143. HaploX Recent Developments
Table 144. HefeiLaierBiotechnologyCo.,Ltd Basic Information
Table 145. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Overview
Table 146. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Revenue (M USD) and Gross Margin (2020-2025)
Table 147. HefeiLaierBiotechnologyCo.,Ltd Business Overview
Table 148. HefeiLaierBiotechnologyCo.,Ltd Recent Developments
Table 149. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 150. North America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Europe Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Type (2026-2035) & (M USD)
Table 156. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Multi-cancer Early Detection (MCED) Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD), 2025-2035
Figure 5. Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Multi-cancer Early Detection (MCED) Tests Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Multi-cancer Early Detection (MCED) Tests Product Life Cycle
Figure 12. Global Multi-cancer Early Detection (MCED) Tests Revenue Share by Company in 2025
Figure 13. Multi-cancer Early Detection (MCED) Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Multi-cancer Early Detection (MCED) Tests Revenue in 2025
Figure 15. Value Chain Map of Multi-cancer Early Detection (MCED) Tests
Figure 16. Global Multi-cancer Early Detection (MCED) Tests Market PEST Analysis
Figure 17. Global Multi-cancer Early Detection (MCED) Tests Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Multi-cancer Early Detection (MCED) Tests Market Share by Type
Figure 20. Market Share of Multi-cancer Early Detection (MCED) Tests by Type (2020-2025)
Figure 21. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application
Figure 24. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application (2020-2025)
Figure 25. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application in 2024
Figure 26. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region (2020-2025)
Figure 28. North America Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Country in 2024
Figure 30. U.S. Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Multi-cancer Early Detection (MCED) Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Multi-cancer Early Detection (MCED) Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country in 2024
Figure 35. Germany Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region in 2024
Figure 42. China Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (M USD)
Figure 48. South America Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Country in 2024
Figure 49. Brazil Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Type (2026-2035)
Figure 61. Global Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Multi-cancer Early Detection (MCED) Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD), 2025-2035
Figure 5. Global Multi-cancer Early Detection (MCED) Tests Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Multi-cancer Early Detection (MCED) Tests Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Multi-cancer Early Detection (MCED) Tests Product Life Cycle
Figure 12. Global Multi-cancer Early Detection (MCED) Tests Revenue Share by Company in 2025
Figure 13. Multi-cancer Early Detection (MCED) Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Multi-cancer Early Detection (MCED) Tests Revenue in 2025
Figure 15. Value Chain Map of Multi-cancer Early Detection (MCED) Tests
Figure 16. Global Multi-cancer Early Detection (MCED) Tests Market PEST Analysis
Figure 17. Global Multi-cancer Early Detection (MCED) Tests Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Multi-cancer Early Detection (MCED) Tests Market Share by Type
Figure 20. Market Share of Multi-cancer Early Detection (MCED) Tests by Type (2020-2025)
Figure 21. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application
Figure 24. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application (2020-2025)
Figure 25. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application in 2024
Figure 26. Global Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region (2020-2025)
Figure 28. North America Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Country in 2024
Figure 30. U.S. Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Multi-cancer Early Detection (MCED) Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Multi-cancer Early Detection (MCED) Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country in 2024
Figure 35. Germany Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region in 2024
Figure 42. China Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (M USD)
Figure 48. South America Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Country in 2024
Figure 49. Brazil Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Multi-cancer Early Detection (MCED) Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Type (2026-2035)
Figure 61. Global Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Application (2026-2035)
